Forced expression of RDH10 gene retards growth of HepG2 cells

Cancer Biology and Therapy

Volumn 6, Issue 2, 2007, Pages 238-245

  Rossi, Elena ^a   Picozzi, Paola ^b   Bodega, Beatrice ^a   Lavazza, Cistiana ^a,c   Carlo Stella, Carmelo ^a,c   Marozzi, Anna ^a   Ginelli, Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell growth arrest; HCC; HepG2; p21; RAR ; RDH10 overexpression; Retinoic acid

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; PROTEIN P21; RETINOIC ACID; RETINOL DEHYDROGENASE; RETINOL DEHYDROGENASE 10; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; REGULATORY MECHANISM; REPORTER GENE;

EID: 34247353741     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.2.3625     Document Type: Article

References (43)

1. Means AL, Gudas LJ. The roles of retinoids in vertebrate development. Annu Rev Biochem 1995; 64:201-33.
2. Clagett-Dame M, DeLuca HF. The role of vitamin A in mammalian reproduction and embryonic development. Annu Rev Nutr 2002;22:347-81.
3. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10:940-54.
4. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 2003; 143-144:201-10.
5. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: Production of visual pigment and retinoic acid. Eur J Biochem 2000; 267:4315-24.
6. Liden M, Tryggvason K, Eriksson U. Structure and function of retinol dehydrogenases of the short chain dehydrogenase/reductase family. Mol Aspects Med 2003; 24:403-9.
7. Soref CM, Di YP, Hayden L, Zhao YH, Satre MA, Wu R. Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/ reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol. J Biol Chem 2001; 276:24194-202.
8. Wu BX, Chen Y, Chen Y, Fan J, Rohrer B, Crouch RK, Ma JX. Cloning and characterization of a novel all-trans retinol short-chain dehydrogenase/ reductase from the RPE. Invest Ophthalmol Vis Sci 2002; 43:3365-72.
9. Picozzi P, Marozzi A, Fornasari D, Benfante R, Barisani D, Meneveri R, Ginelli E. Genomic organization and transcription of the human retinol dehydrogenase 10 (RDH10) gene. FEBS Lett 2003; 554:59-66.
10. Ross AC, Zolfaghari R. Regulation of hepatic retinol metabolism: Perspectives from studies on vitamin A status. J Nutr 2004; 134:269S-275S.
11. Teixeira C, Pratt MA. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 1997; 11:1191-202.
12. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 1998; 58:3163-72.
13. Matsuo T, Thiele CJ. p27Kip1: A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene1998;16:3337-43.
14. Falasca L, Marcellini P, Ara C, Rufo A, Devirgiliis LC. Growth inhibition and induction of specific hepatic phenotype expression by retinoic acid in HEPG2 cells. Anticancer Res 1999; 19:3283-92.
15. Baldassarre G, Boccia A, Bruni P, Sandomenico C, Barone MV, Pepe S, Angrisano T, Belletti B, Motti ML, Fusco A, Viglietto G. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Differ 2000; 11:517-26.
16. Guidoboni M, Zancai P, Cariati R, Rizzo S, DalCol J, Pavan A, Gloghini A, Spina M, Cuneo A, Pomponi F, Bononi A, Doglioni C, Maestro R, Carbone A, Boiocchi M, Dolcetti R. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res 2005; 65:587-95.
17. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72:567-72.
18. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992; 3:513-26.
19. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group N Engl J Med 1996; 334:1561-7.
20. Kojima S, Okuno M, Matsushima-Nishiwaki R, Friedman SL, Moriwaki H. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma. Int J Oncol 2004; 24:797-805.
21. Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 2002; 62:3997-4006.
22. Alisi A, Leoni S, Piacentani A, Conti Devirgiliis L. Retinoic acid modulates the cell-cycle in fetal rat hepatocytes and HepG2 cells by regulating cyclin-cdk activities. Liver Int 2003; 23:179-86.
23. Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. Mol Cancer Ther 2004; 3:309-16.
24. 1 arrest in hepatocellular carcinoma cells. Hepatol Res 2005; 31:143-152.
25. Liu M, Iavarone A, Freedman LP. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor: Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 1996; 271:31723-8.
26. Segalla S, Rinaldi L, Kilstrup-Nielsen C, Badaracco G, Minucci S, Pelicci PG, Landsberger N. Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties. Mol Cell Biol 2003; 23:8795-808.
27. Lee MO, Manthey CL, Sladek NE. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. Biochem Pharmacol 1991; 42:1279-85.
28. Wu BX, Moiseyev G, Chen Y, Rohrer B, Crouch RK, Ma JX. Identification of RDH10, an all-trans retinol dehydrogenase, in retinal muller cells. Invest Ophthalmol Vis Sci 2004; 45:3857-62.
29. Harding PP, Duester G. Retinoic acid activation and thyroid hormone repression of the human alcohol dehydrogenase gene ADH3. J Biol Chem 1992; 267:14145-50.
30. Bhattacharyya N, Dey A, Minucci S, Zimmer A, John S, Hager G, Ozato K. Retinoid-induced chromatin structure alterations in the retinoic acid receptor beta2 promoter. Mol Cell Biol 1997; 17:6481-90.
31. Chang C, Hsu LC, Dave VV, Yoshida A. Expression of human aldehyde dehydrogenase-3 associated with hepatocellular carcinoma: Promoter regions and nuclear protein factors related to the expression. Int J Mol Med 1998; 2:333-338.
32. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001; 1:181-93.
33. Sun SY, Wan H, Yue P, Hong WK, Lotan R. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J Biol Chem 2000; 275:17149-53.
34. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997; 99:403-13.
35. Gartel AL, Tyner AL. The growth-regulatory role of p21 (WAF1/CIP1). Prog Mol Subcell Biol 1998; 20:43-71.
36. Stevens C, La Thangue NB. E2F and cell cycle control: A double-edged sword. Arch Biochem Biophys 2003; 412:157-69.
37. Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol 2003; 36(1):60-5.
38. Weinstein IB. Disorders in cell circuitry during multistage carcinogenesis: The role of homeostasis. Carcinogenesis 2000; 21:857-64.
39. Xia D, Zhang MM, Yan LN. Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int 2004; 3:332-6.
40. Avila MA, Baresain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene 2006; 25:3866-84.
41. Hwang LH. Gene therapy strategies for hepatocellular carcinoma. J Biomed Sci 2006; 13:453-68.
42. Smith MA, Anderson B. Where to next with retinoids for cancer therapy? Clin Cancer Res 2001; 7:2955-7.
43. Larson RS, Tallman MS. Retinoic acid syndrome: Manifestations, pathogenesis, and treatment. Best Pract Res Clin Haematol 2003; 16:453-61.